Urinary incontinence (UI) can affect patients' quality of life negatively as UI is associated with significant social embarrassment, altered self-image, difficulties in intimate relationships, isolation, and hopelessness. The historical management strategies for addressing UI in women has incorporated various devices, medications, and surgeries. The evolution of surgery for UI spanned thousands of years to arrive at the current standards of surgical care, which is divided between management of stress UI or urge UI. This article discusses the evolution of UI treatments, with a focus on surgical management, while introducing some emerging technologies. (J GYNECOL SURG 38:197)
Get full access to this article
View all access options for this article.
References
1.
LukaczES, Santiago-LastraY, AlboME, BrubakerL. Urinary incontinence in women: A review. JAMA, 2017; 318:1592.
2.
WoodLN, AngerJT. Urinary incontinence in women. BMJ, 2014; 349:g4531.
3.
BuckleyBS, Lapitan MC; Epidemiology Committee of the Fourth International Consultation onIncontinence, Paris 2008. Prevalence of urinary incontinence in men, women, and children—current evidence: Findings of the Fourth International Consultation on Incontinence. Urology, 2010; 76:265.
4.
ShokeirAA, HusseinMI. The urology of Pharaonic Egypt. BJU Int, 1999; 84:755.
BurchJC. Urethrovaginal fixation to Cooper's ligament for correction of stress incontinence, cystocele, and prolapse. Am J Obstet Gynecol, 1961; 81:281.
16.
TanaghoEA. Colpocystourethropexy: The way we do it. J Urol, 1976; 116:751.
17.
FrancisSL, AgrawalA, AzadiA, et al.Robotic Burch colposuspension: A surgical case and instructional video. Int Urogynecol J, 2015; 26:147.
18.
PetrosPE, UlmstenUI. An integral theory of female urinary incontinence: Experimental and clinical considerations. Acta Obstet Gynecol Scand, 1990; 153(suppl):7.
19.
PricePB. Plastics operations for incontinence of urine and feces. Arch Surg, 1933; 26:1043.
20.
GomesCM, CarvalhoFL, BellucciCHS, et al.Update on complications of synthetic suburethral slings. Int Braz J Urol, 2017; 43:822.
LiH, WestneyOL. Injection of urethral bulking agents. Urol Clin North Am, 2019; 46:1.
23.
U.S. Food and Drug Administration. Summary of Safety and Effectiveness Data (SSED) [for Bulkamid® Urethral Bulking System]. Online document at: www.accessdata.fda.gov/cdrh_docs/pdf17/P170023B.pdf Accessed May18, 2022.
24.
KirchinV, PageT, KeeganPE, et al.Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev, 2017; 7:CD003881.
25.
GajewskiJB, HassounaMM, CorcosJ, et al.The history of sacral neuromodulation in Canada. Can Urol Assoc J, 2020; 14:87.
26.
AmmiratiE, GiammòA, ManasseroA, et al.Neuromodulation in urology, state of the art. Urologia, 2019; 86:177.
27.
OelkeM, AddaliM, ReisenauerC. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder. Arch Gynecol Obstet, 2019; 299:1243.
28.
Fempulsetm: The Elegant Solution.tm Empowering Women Worldwide with Wearable Bioelectronic Medicine. Online document at: https://fempulse.com/home/ Accessed May18, 2022.
